Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL16228497

O=C(C=Cc1ccc2c(c1)CCNC2)N1CCCC1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ MAOB P27338 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ TRPV1 Q8NER1 2/20 0.45
▸ MEN1 O00255 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ PLAU P00749 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ PELI1 Q96FA3 1/20 0.42
▸ ALOX5 P09917 1/20 0.40
▸ GPR183 P32249 1/20 0.40
▸ KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL16228496 1.00 ALDH1A1 (0.46) ALDH1A1KMT2AMAOBKDM4ENPC1
SCHEMBL16231782 0.92 ALDH1A1 (0.52) ALDH1A1KMT2AMAOBKDM4ENPC1
SCHEMBL16230824 0.77 ESR1 (0.58) ALDH1A1KMT2AMAOBKDM4ENPC1
Trifluoroacetic Acid SCHEMBL7254528 0.73 DRD2 (0.49) —
1,2,3,4-Tetrahydroisoquinoline SCHEMBL29710285 0.69 PNMT (0.66) MAOB
1,2,3,4-Tetrahydroisoquinoline SCHEMBL1788708 0.69 PNMT (0.66) MAOB
Trifluoroacetic Acid SCHEMBL1580125 0.69 POLB (0.68) ALDH1A1KMT2AKDM4ENPC1RAB9A
Trifluoroacetic Acid SCHEMBL1580123 0.69 POLB (0.68) ALDH1A1KMT2AKDM4ENPC1RAB9A
SCHEMBL13469392 0.69 ALOX5 (0.67) ALDH1A1KMT2AMAOBKDM4ENPC1
SCHEMBL14995212 0.68 ESR2 (0.61) ALDH1A1KMT2AMAOBKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062002-B2 Substituted pyridine derivatives as FabI inhibitors AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2015-06-23 — — US disclosed
US-20140336153-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS FABI INHIBITORS AURIGENE DISCOVERY TECH LTD (IN) 2014-11-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140336153-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS FABI INHIBITORS F12, FAR1, NQO2 ALDH1A1 1613/4885KMT2A 4203/4885MAOB 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback